FIXLIV-200 is a broad-spectrum cephalosporin antibiotic tablet that contains Cefixime Dispersible Tablets, offered by Yodley Life Sciences. The dispersible form makes it more convenient to use – tablets can either be swallowed directly or dissolved in water – making it a favourable option for patients who find it hard to swallow regular tablets, including the elderly and children. Cefixime is a drug of the third-generation cephalosporin group, and it is highly regarded as a drug that effectively treats different kinds of bacterial infections.

Produced in a WHO-GMP-approved facility and packed in a 10×10 Alu-Alu blister, these Cefixime Dispersible Tablets are a true reflection of the quality products Yodley Life Sciences provides.

Composition

• Cefixime 200 mg (as Dispersible Tablets I.P.)

Uses and Indications

FIXLIV-200 Tablets are prescribed by physicians, paediatricians, and general practitioners for the management of:

• Upper and lower respiratory tract infections (pharyngitis, tonsillitis, bronchitis, pneumonia)
• Urinary tract infections (uncomplicated UTIs) caused by susceptible organisms
• Otitis media (middle ear infections) in adults and children
• Typhoid fever and enteric fever (in combination with other agents, as directed)
• Gonorrhoea (uncomplicated cervical/urethral) caused by Neisseria gonorrhoeae
• Skin and soft tissue infections due to susceptible gram-negative bacteria
• Adjunct therapy for upper respiratory infections of bacterial origin

How Cefixime Dispersible Tablets Work

Cefixime is an antibiotic of third generation and an orally administered cephalosporin. It has its antibacterial effect through interference in the process of bacterial cell wall synthesis. The mechanism of action is achieved by inhibition of peptidoglycan chain cross-linking through binding to penicillin-binding proteins located inside the bacterial cell membrane. Cefixime has a wide spectrum of antibacterial action against gram-negative bacteria with some action on gram-positive bacteria and a long half-life, which makes it suitable for administration once or twice daily.

Dosage and Administration

FIXLIV-200 Dispersible tablets are meant for oral use only. The drug may be administered whole in water or in a suspension after dissolving it in a small quantity of water. The dosage, the frequency of administration, and the period of time the therapy must be continued are as recommended by a licensed doctor depending on the nature and degree of infection and the age, weight, and renal function of the patient.

Side Effects

FIXLIV-200 is generally well tolerated. However, some patients may experience mild and transient effects, including:

• Nausea, vomiting, or diarrhoea
• Abdominal pain or gastric discomfort
• Headache or dizziness
• Skin rash, itching, or urticaria
• Rarely, pseudomembranous colitis (seek medical attention immediately)
• Rarely, hypersensitivity reactions including anaphylaxis in penicillin-sensitive individuals

Patients experiencing persistent or severe side effects should discontinue use and consult their physician promptly.

Precautions and Warnings

• To be taken only under medical supervision; take the entire course as prescribed
• Let your healthcare provider know if you have any allergic reaction to cephalosporins, penicillin, or beta-lactams
• Take carefully in case of renal disorders; dosage adjustment might be necessary
• Discuss pregnancy or breastfeeding conditions with the prescribing physician prior to use
• Be alert for superinfection or Clostridium difficile infection-associated diarrhoea
• Co-administration with warfarin can potentiate its anticoagulant action; be vigilant
• Keep out of the reach of children
• Never exceed the prescribed dose or duration

Contraindications

FIXLIV-200 should not be used in patients with known hypersensitivity to Cefixime, cephalosporins, or any component of the formulation. It should be used with caution in patients with a history of penicillin allergy due to potential cross-reactivity.

Storage Instructions

Store FIXLIV-200 Tablets below 25°C, in a dry place, protected from light and moisture. Keep in the original Alu-Alu blister pack until use, and store out of reach of children and pets.

Packing Information

PCD Pharma Franchise for Cefixime Dispersible Tablets – Yodley Life Sciences Pvt. Ltd.

Yodley Life Sciences invites pharma professionals, distributors, and medical representatives across India to partner for the PCD Pharma Franchise and Monopoly Distribution rights of Cefixime Dispersible Tablets. As a leading WHO-GMP certified pharmaceutical company with a 500+ product portfolio and a strong presence across India and overseas, Yodley Life Sciences offers unmatched franchise opportunities in the antibiotic and general medicine segment.

Why Choose Yodley Life Sciences for PCD Pharma Franchise of Cefixime Dispersible Tablets?

• Monopoly-based PCD Pharma Franchise rights for FIXLIV-200 and the entire Yodley product range across district/state level
• Attractive profit margins and highly competitive pricing across all product categories
• WHO-GMP certified manufacturing ensuring consistent quality and 100% efficacy
• 500+ product portfolio covering tablets, capsules, syrups, injections, suspensions, dry syrups, and ayurvedic formulations
• Free promotional inputs – visual aids, MR bags, sample kits, reminder cards, and product literature
• Pan-India delivery with on-time order fulfilment and reliable supply chain
• Dedicated franchise support team for onboarding and ongoing business growth

Who Can Apply?

• Pharma professionals, distributors, and stockists looking to expand their antibiotic/general portfolio
• Medical representatives seeking to start their own independent PCD pharma business
• Existing pharma franchise partners wanting monopoly rights for FIXLIV-200 in their territory

For PCD Pharma Franchise enquiries for FIXLIV-200 and the complete Yodley Life Sciences product range, contact us today and become part of a fast-growing, quality-driven pharmaceutical network.

Disclaimer: FIXLIV-200 is a medicinal product. Use strictly under the supervision of a registered medical practitioner. This document is for informational and franchise marketing purposes only and does not constitute medical advice.